Putting the award page together from the records…
Putting the award page together from the records…
Glaxosmithkline, LLC received this contract vehicle from CDC Office of Acquisition Services, Centers for Disease Control and Prevention: $81.30M obligated so far for drugs and biologicals. It runs to 2027-02-28.
Key facts · data as of Oct 22, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Award 75D30126D20724, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_IDV_75D30126D20724_7523
Glaxosmithkline, LLC: all federal awards · Department of Health and Human Services: spending · CDC Office of Acquisition Services: what it buys · The follow-on: recompete brief
PEDIATRIC FLU VACCINES
Up for re-bid: ends 2027-02-28. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
5 actions since 2025-12-29. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-21 | P00003 | Administrative change | $0 | PEDIATRIC FLU VACCINES |
| 2026-06-09 | P00004 | Administrative change | $0 | EO 14398 |
| 2026-05-13 | P00002 | Supplemental agreement (work within scope) | $3.82M | PEDIATRIC FLU VACCINES |
| 2026-03-13 | P00001 | Funding only | $77.48M | PEDIATRIC FLU VACCINES |
| 2025-12-29 | 0 | $3.0K | PEDIATRIC FLU VACCINES |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗